Volume 24, Number 1—January 2018
CME ACTIVITY - Synopsis
Zika Virus Testing and Outcomes during Pregnancy, Florida, USA, 2016
Colette Shiu1, Rebecca Starker1, Jaclyn Kwal, Michelle Bartlett, Anise Crane, Samantha Greissman, Naiomi Gunaratne, Meghan Lardy, Michelle Picon, Patricia Rodriguez, Ivan Gonzalez, and Christine L. Curry
Table 3
Characteristics of 86 women with laboratory evidence of Zika virus infection during pregnancy, Miami–Dade County, Florida, USA, 2016
| Characteristic | No. (%) |
|---|---|
| Gravidity | |
| 1 | 27 (31.0) |
| >2 |
59 (68.6) |
| Parity | |
| 0 | 8 (9.3) |
| 1 | 39 (45.3) |
| >2 |
39 (45.3) |
| Reason tested | |
| Asymptomatic | 53 (61.6) |
| Symptomatic | 14 (16.2) |
| Not determined |
19 (22.1) |
| Pregnancy outcome | |
| Preterm delivery | 8 (9.3) |
| Term delivery | 44 (51.1) |
| Still pregnant |
34 (39.5) |
| Location of virus acquisition | |
| Local | 40 (46.5) |
| During travel | 26 (30.2) |
| Both | 15 (17.4) |
| Undetermined |
5 (5.8) |
| Follow-up | |
| Lost to follow-up | 23 (26.7) |
| Continued care | 63 (73.3) |
1These authors contributed equally to this article.
Page created: December 18, 2017
Page updated: December 18, 2017
Page reviewed: December 18, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.